ArticleOncotarget2017

Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures.

Indranil Chattopadhyay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.